BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 20443565)

  • 21. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
    Qu Y; Scarsdale NJ; Tran MC; Farrell NP
    J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J; Vojtiskova M; Natile G; Brabec V
    Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA cross-linking patterns induced by an antitumor-active trinuclear platinum complex and comparison with its dinuclear analogue.
    Zhu J; Zhao Y; Zhu Y; Wu Z; Lin M; He W; Wang Y; Chen G; Dong L; Zhang J; Lu Y; Guo Z
    Chemistry; 2009; 15(21):5245-53. PubMed ID: 19350599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
    Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG
    Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
    Ouzon-Shubeita H; Baker M; Koag MC; Lee S
    Biochem J; 2019 Feb; 476(4):747-758. PubMed ID: 30709915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464.
    Zehnulova J; Kasparkova J; Farrell N; Brabec V
    J Biol Chem; 2001 Jun; 276(25):22191-9. PubMed ID: 11303029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY; Wilson JJ; Song Y; Lippard SJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
    Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
    Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of transcription by platinated triplex-forming oligonucleotides.
    Graham MK; Miller PS
    J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the mechanism underlying the synergistic action of ionizing radiation with platinum chemotherapeutic drugs: the role of low-energy electrons.
    Rezaee M; Hunting DJ; Sanche L
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):847-53. PubMed ID: 23910707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers.
    Zerzankova L; Kostrhunova H; Vojtiskova M; Novakova O; Suchankova T; Lin M; Guo Z; Kasparkova J; Brabec V
    Biochem Pharmacol; 2010 Aug; 80(3):344-51. PubMed ID: 20399754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
    J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular aspects of drugs of the future: oxaliplatin.
    Di Francesco AM; Ruggiero A; Riccardi R
    Cell Mol Life Sci; 2002 Nov; 59(11):1914-27. PubMed ID: 12530522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.
    Guggenheim ER; Xu D; Zhang CX; Chang PV; Lippard SJ
    Chembiochem; 2009 Jan; 10(1):141-57. PubMed ID: 19053130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions.
    Muchova T; Quintal SM; Farrell NP; Brabec V; Kasparkova J
    J Biol Inorg Chem; 2012 Feb; 17(2):239-45. PubMed ID: 21938443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a liquid chromatography-electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples.
    Le Pla RC; Ritchie KJ; Henderson CJ; Wolf CR; Harrington CF; Farmer PB
    Chem Res Toxicol; 2007 Aug; 20(8):1177-82. PubMed ID: 17636892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA.
    Woynarowski JM; Chapman WG; Napier C; Herzig MC; Juniewicz P
    Mol Pharmacol; 1998 Nov; 54(5):770-7. PubMed ID: 9804612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural consequences of a 3'-->3' DNA interstrand cross-link by a trinuclear platinum complex: unique formation of two such cross-links in a 10-mer duplex.
    Qu Y; Tran MC; Farrell NP
    J Biol Inorg Chem; 2009 Aug; 14(6):969-77. PubMed ID: 19415349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.